"Looks like Merck is repackaging the 'horse drug' and making it more expensive! It will be the 'new' treatment for (COVID-19) in pill form," reads an Oct. 2 Facebook post, referring to Merck's ...

Coronavirus. Merck’s promising experimental Covid-19 drug raises hopes for pill to fight virus If those promising preliminary results hold, the new drug could help fill a significant gap in the ...

Merck isn't the only pharmaceutical company making an antiviral pill for COVID-19. But Merck's pill is farther along in the process and could become the first antiviral drug approved to be taken ...

Merck's new COVID drug molnupiravir gets FDA consideration : Shots - Health News The FDA is considering new pills that could treat people in early stages of COVID. Here's what to know about how ...

Merck’s new COVID-19 drug could be a pandemic “game-changer” The drug's clinical trial showed great promise for reducing deaths of COVID-19 patients.

At the beginning of October, Merck announced that its drug candidate molnupiravir, an oral antiviral, was shown to halve the risk of hospitalization or death from Covid-19 when given to high-risk ...

Merck & Co.’s COVID-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen’s ...

Merck announced preliminary results last month showing its drug cut hospitalizations and deaths by half among patients with early COVID-19 symptoms. The results have not yet been vetted by outside ...

Molnupiravir, an antiviral drug made by Merck and Ridgeback Pharmaceuticals, may prevent some hospitalizations and deaths from COVID-19, but researchers say it has drawbacks that could limit its ...

Merck’s COVID-19 Antiviral Drug Cuts Hospitalizations and Deaths by Half. 3 minute read. An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and ...

An experimental COVID-19 treatment pill, called molnupiravir, developed by Merck & Co Inc and Ridgeback Biotherapeutics LP. Merck & Co Inc/Handout via REUTERS ...

A panel of experts advising the Food and Drug Administration voted narrowly in favor of emergency use authorization of an antiviral pill from Merck and Ridgeback Biotherapeutics to treat COVID-19.